Inhalable form of gene-therapy takes aim at lung cancer and inflammatory lung disease

A new inhalable form of gene therapy — based on technology recognized in the 2006 Nobel medicine prize, shows increasing promise for treating lung cancer, infectious diseases and inflammatory lung disease, scientists have concluded after an exhaustive review of worldwide research on the topic. Their report is scheduled for the June 2 issue of ACS' Molecular Pharmaceutics.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news132234633.html">Inhalable form of gene-therapy takes aim at lung cancer and inflammatory lung disease</a></p> <p>A new inhalable form of gene therapy — based on technology recognized in the 2006 Nobel medicine prize, shows increasing promise for treating lung cancer, infectious diseases and inflammatory lung disease, scientists have concluded after an exhaustive review of worldwide research on the topic. Their report is scheduled for the June 2 issue of ACS' <i>Molecular Pharmaceutics</i>.</p>